, Tracking Stock Market Picks
Enter Symbol:
Cytokinetics, Incorporated (CYTK) [hlAlert]

up 66.17 %

Cytokinetics, Incorporated (CYTK) upgraded to Buy with price target $2.50 by Needham

Posted on: Monday,  Jul 2, 2012  8:25 AM ET by Needham

Needham rated Buy Cytokinetics, Incorporated (NASDAQ: CYTK) on 07/02/2012, when the stock price was $4.08. Since
then, Cytokinetics, Incorporated has gained 66.18% as of 01/06/2016's recent price of $6.78.
If you would have followed this Needham's recommendation on CYTK, you would have gained 66.17% of your investment in 1283 days.

Cytokinetics Inc

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/2/2012 8:25 AM Buy
4.08 15.00
as of 12/31/2012
1 Week down  -1.49 %
1 Month up  3.12 %
3 Months down  -20.48 %
1 YTD down  -2.94 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/29/2009 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy